| Strength: | |
|---|---|
| Quantity: | |
Brief Introduction:
National Medical Insurance, Category B.
Launched in 1999 and awarded as an excellent brand of biological and biochemical products in China's ChemPharm industry.
National standard bulk supplier of Filgrastim. Participated in the development and collaborative calibration of Filgrastim national reference standards.
Participated in the collaborative calibration of Filgrastim reference standard organized by USP, WHO and other international organizations.
Indications:
Neutropenia resulting from cancer chemotherapy. For details, please refer to Instructions.
Academic progress
Guideline Express: NCCN Clinical Practice Guidelines in Oncology: Hematopoietic Growth Factors (2020V2)
2020-03-13
Research Progress: Granulocyte colony-stimulating factor in treatment of unexplained recurrent spontaneous abortion
2020-03-10
Research Progress: Effectiveness of intrauterine infusion of granulocyte colony-stimulating factor for thin endometrium: a systematic review and meta-analysis
2020-03-10
Guideline Express: Guidelines for standardized management of neutropenia induced by chemotherapy and radiotherapy
2020-03-10
Research Progress: Granulocyte colony-stimulating factor in repeated IVF failure, a randomized trial
2020-03-10
Guideline Express: ASBMIT new guidelines for peripheral blood progenitor cell mobilization issued
2020-03-10
Guideline Express: Consensus on the clinical diagnosis, treatment, and prevention of chemotherapy-induced neutropenia in China (2019 edition)
2020-03-09
Brief Introduction:
National Medical Insurance, Category B.
Launched in 1999 and awarded as an excellent brand of biological and biochemical products in China's ChemPharm industry.
National standard bulk supplier of Filgrastim. Participated in the development and collaborative calibration of Filgrastim national reference standards.
Participated in the collaborative calibration of Filgrastim reference standard organized by USP, WHO and other international organizations.
Indications:
Neutropenia resulting from cancer chemotherapy. For details, please refer to Instructions.
Academic progress
Guideline Express: NCCN Clinical Practice Guidelines in Oncology: Hematopoietic Growth Factors (2020V2)
2020-03-13
Research Progress: Granulocyte colony-stimulating factor in treatment of unexplained recurrent spontaneous abortion
2020-03-10
Research Progress: Effectiveness of intrauterine infusion of granulocyte colony-stimulating factor for thin endometrium: a systematic review and meta-analysis
2020-03-10
Guideline Express: Guidelines for standardized management of neutropenia induced by chemotherapy and radiotherapy
2020-03-10
Research Progress: Granulocyte colony-stimulating factor in repeated IVF failure, a randomized trial
2020-03-10
Guideline Express: ASBMIT new guidelines for peripheral blood progenitor cell mobilization issued
2020-03-10
Guideline Express: Consensus on the clinical diagnosis, treatment, and prevention of chemotherapy-induced neutropenia in China (2019 edition)
2020-03-09
